TD Cowen Initiates Coverage On SI-BONE with Buy Rating, Announces Price Target of $21

1/27/2026
Impact: 70
Healthcare

TD Cowen analyst Mathew Blackman has initiated coverage on SI-BONE (NASDAQ: SIBN) with a Buy rating. The firm has set a price target of $21 for the stock.

AI summary, not financial advice

Share: